Viking Therapeutics logo

Viking Therapeutics share price today

(NASDAQ: VKTX)

Viking Therapeutics share price is $34.94 & ₹3,021.96 as on 24 Jan 2025, 2.30 'hrs' IST

$34.94

0.89

(2.61%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Viking Therapeutics share price in Dollar and Rupees. Guide to invest in Viking Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Viking Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Viking Therapeutics share price movements

  • Today's Low: $32.54
    Today's High: $35.10

    Day's Volatility :7.3%

  • 52 Weeks Low: $20.92
    52 Weeks High: $99.41

    52 Weeks Volatility :78.96%

Viking Therapeutics Returns

PeriodViking Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-56.36%
-5.5%
0.0%
6 Months
-48.39%
-4.3%
0.0%
1 Year
58.3%
1.6%
0.0%
3 Years
859.15%
9.8%
-11.0%

Viking Therapeutics Key Statistics

in dollars & INR

Previous Close
$34.05
Open
$33.85
Today's High
$35.1033
Today's Low
$32.54
Market Capitalization
$3.7B
Today's Volume
$4.4M
52 Week High
$99.41
52 Week Low
$20.92
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-15.5%

How to invest in Viking Therapeutics Stock (VKTX) from India?

It is very easy for Indian residents to invest directly in Viking Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viking Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viking Therapeutics or VKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viking Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viking Therapeutics shares which would translate to 0.025 fractional shares of Viking Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Viking Therapeutics, in just a few clicks!

Returns in Viking Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viking Therapeutics investment value today

Current value as on today

₹1,66,490

Returns

₹66,490

(+66.49%)

Returns from Viking Therapeutics Stock

₹62,436 (+62.44%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Viking Therapeutics

-23.05%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Investment in Viking Therapeutics from India has reduced in the last 30 days as on Jan 24, 2025. -23.05% less purchase transactions for Viking Therapeutics in the last 30 days versus the previous period.

-48%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Viking Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -48% less investors are searching Viking Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Viking Therapeutics

  • FMR Inc

    14.91%

  • Vanguard Group Inc

    9.12%

  • BlackRock Inc

    4.83%

  • State Street Corp

    4.19%

  • JPMorgan Chase & Co

    1.90%

  • Morgan Stanley - Brokerage Accounts

    1.68%

Analyst Recommendation on Viking Therapeutics

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Viking Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Viking Therapeutics

What analysts predicted

Upside of 214.83%

Target:

$110.00

Current:

$34.94

Insights on Viking Therapeutics

  • Price Movement

    In the last 3 years, VKTX stock has moved up by 793.7%

Viking Therapeutics Technicals Summary

Sell

Neutral

Buy

Viking Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Viking Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Viking Therapeutics, Inc. logo
-19.6%
-48.39%
58.3%
859.15%
438.77%
Biontech Se logo
0.91%
34.01%
18.85%
-26.4%
246.9%
Regeneron Pharmaceuticals, Inc. logo
-4.82%
-36.95%
-28.33%
12.74%
100.35%
Vertex Pharmaceuticals Incorporated logo
4.86%
-13.58%
-0.46%
88.45%
88.24%
Alnylam Pharmaceuticals, Inc. logo
9.57%
13.5%
44.91%
103.56%
127.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Viking Therapeutics, Inc. logo
NA
NA
-0.03
-0.96
-0.15
-0.13
NA
8.18
Biontech Se logo
160.8
NA
0.04
-3.33
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.02
17.02
1.05
44.99
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.1
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Viking Therapeutics, Inc. logo
Buy
$3.7B
438.77%
NA
0.0%
Biontech Se logo
Buy
$28.1B
246.9%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.6B
100.35%
17.02
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$110.2B
88.24%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.2B
127.75%
NA
-15.86%

Viking Therapeutics Dividend announcements

  • Viking Therapeutics Earnings

    Viking Therapeutics’s price-to-earnings ratio stands at None

    Read More

About Viking Therapeutics

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Organization
Viking Therapeutics
Employees
30
CEO
Dr. Brian Lian Ph.D.
Industry
Health Technology

Management People of Viking Therapeutics

NameTitle
Dr. Brian Lian Ph.D.
President, CEO & Director
Mr. Gregory S. Zante CPA, CPA
Chief Financial Officer
Ms. Marianne Mancini
Chief Operating Officer
Mr. Michael Morneau
Vice President of Finance & Administration
Dr. Geoffrey E. Barker Ph.D.
Senior Vice President of Pharmaceutical Development

Important FAQs about investing in Viking Therapeutics (VKTX) from India :

What is Viking Therapeutics share price today?

Viking Therapeutics share price today stands at $34.94, Open: $33.85 ; Previous Close: $34.05 ; High: $35.10 ; Low: $32.54 ; 52 Week High: $99.41 ; 52 Week Low: $20.92. The stock opens at $33.85, after a previous close of $34.05. The stock reached a daily high of $35.10 and a low of $32.54, with a 52-week high of $99.41 and a 52-week low of $20.92.

Can Indians buy Viking Therapeutics shares?

Yes, Indians can invest in the Viking Therapeutics (VKTX) from India.

With INDmoney, you can buy Viking Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Viking Therapeutics at zero transaction cost.

How can I buy Viking Therapeutics shares from India?

It is very easy to buy Viking Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viking Therapeutics be purchased?

Yes, you can buy fractional shares of Viking Therapeutics with INDmoney app.

What are the documents required to start investing in Viking Therapeutics stocks?

To start investing in Viking Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Viking Therapeutics

Today’s highest price of Viking Therapeutics (VKTX) is $35.10.

Today’s lowest price of Viking Therapeutics (VKTX) is $32.54.

What is today's market capitalisation of Viking Therapeutics

Today's market capitalisation of Viking Therapeutics VKTX is 3.7B

What is the 52 Week High and Low Range of Viking Therapeutics

  • 52 Week High

    $99.41

  • 52 Week Low

    $20.92

What are the historical returns of Viking Therapeutics?

  • 1 Month Returns

    -19.6%

  • 3 Months Returns

    -48.39%

  • 1 Year Returns

    58.3%

  • 5 Years Returns

    438.77%

Who is the Chief Executive Officer (CEO) of Viking Therapeutics

Dr. Brian Lian Ph.D. is the current Chief Executive Officer (CEO) of Viking Therapeutics.